Concord Enviro posts ₹17.6 Cr consolidated loss in Q1 FY27 as revenue slumps, costs rise
revenue -16.65% · margins compressing · miss vs street
₹85.35 Cr
-16.65% YoY
₹-17.57 Cr
-19.14%
-22.6pp YoY
₹-8.49
Concord Enviro's consolidated Q1 FY27 print swung to a net loss of ₹17.57 Cr, against a profit of ₹4.12 Cr in Q1 FY26 (YoY) and ₹14.16 Cr in Q4 FY26 (QoQ). No exceptional items were booked in the current or year-ago quarter, so this is an operational swing, not a one-off — Q4 FY26's profit had included a ₹5.18 Cr Labour Code provision reversal that did not recur. Consolidated revenue fell 16.6% YoY to ₹85.35 Cr and 58.6% QoQ from ₹206.04 Cr; Q1 is typically the group's weakest quarter (Q1 FY26 itself ran a thin +5.97% pretax operating margin), but this year's decline is materially steeper. Standalone (India parent-only) results stayed profitable at ₹0.31 Cr PAT, down 92.3% YoY from ₹3.95 Cr — the loss is concentrated outside the parent, in the overseas/subsidiary operations consolidated into the group; this standalone-consolidated divergence (profit vs loss) is wide enough that it needs flagging explicitly.
Q1 FY-2027 vs prior quarters
Operating math: total expenses of ₹110.44 Cr outpaced total income of ₹91.77 Cr, producing a pretax operating loss (before JV share) of ₹18.67 Cr versus +₹6.11 Cr YoY and +₹12.52 Cr QoQ — a swing of roughly 28 percentage points of margin. Employee benefits expense rose 25.6% YoY to ₹30.22 Cr and cost of services rose 39.8% YoY to ₹16.26 Cr, both increasing even as revenue fell, so costs did not flex down with lower execution volume. A further ₹1.04 Cr loss came from the share of joint-venture results (Roserve Enviro, WHE Systems) versus a ₹0.30 Cr profit YoY. Including a ₹0.43 Cr discontinued-operations loss (Blue Water Trading & Treatment FZE, under voluntary liquidation), the total net loss was ₹17.57 Cr; basic EPS was -₹8.49 versus +₹1.99 YoY and +₹6.84 QoQ.
The stock went into the print at ₹276.45, down 16.9% over the past month of trading.
Management provided cautious guidance for FY27, anticipating revenue growth driven by a strong order book, particularly from S&P and export markets, with an order intake target of approximately INR 1,000 crores. While reiterating a target EBITDA margin of 14-16%, they acknowledge short-term cost pressures from geopolit
— This quarter: missed
Against management's own FY27 guidance from the Q4 FY26 call — a 14-16% EBITDA margin target and an order-intake target of ~₹1,000 Cr, while flagging short-term cost pressures from geopolitical events and freight with more clarity expected in Q1 — this print is a clear miss: a pretax margin swing to -21.9% is far deeper than a normal cost-pressure quarter would suggest, though directionally consistent with what management flagged. No management press release accompanying this result was available to cross-check their own framing. Street estimates were not quarter-specific, but Univest's analyst commentary had built 15-20% FY27 PAT growth into a ₹320 price target; a Q1 loss puts that full-year thesis under pressure. Other developments this quarter — CFO Anish Goel's resignation (July 6) and the appointment of Shleshank Laheri as the new CFO effective the same day as this result, a ₹16 Cr wastewater order won by a subsidiary (June 15), continuing NCLT proceedings on the Scheme of Arrangement (June 20), and a post-quarter ₹10.54 Cr investment in subsidiary RSSIPL for capacity expansion (July 9) — sit alongside the weak print without any stated causal link to the loss in the filing.
W1
FY27 order-intake target of ~₹1,000 Cr (management guidance) — this filing discloses no order-book figure; watch for disclosure on the Aug 12 concall
W2
Margin trajectory — Q1 pretax margin (before JV) was -21.9% vs management's 14-16% EBITDA margin target for FY27; watch whether employee costs (+25.6% YoY) and cost of services (+39.8% YoY) normalize in Q2
W3
New CFO Shleshank Laheri (effective Aug 11, 2026) — first commentary on cost control expected on the Aug 12 earnings call
Massive loss masks order strength; recovery unproven
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Sell
confidence 7/10
Grade D
Missed prior quarter by 16.6% revenue; ₹4.1 Cr profit swung to ₹17.6 Cr loss. External factors cited but inadequately quantified.
Negative
next 1–2 quarters
Cautiously Optimistic
multi-year
Q1 delivered a catastrophic loss (₹17.6 Cr, -19.1% NPM) despite management's claims of temporary disruptions. Even accounting for ₹50-55 Cr in attributed lost revenue, the company is structurally unprofitable and management's ₹1,000 Cr order intake / ₹699 Cr book conversion story is unproven. Key risk: execution at scale.
₹85.3 Cr
Revenue · −16.6% YoY₹-17.6 Cr
Reported PAT · −526.5% YoYCompressing
Margins · vs guidance: OverstatedDid the claims hold up?
Supply chain cost ₹50-55 Cr in lost revenue
OVERSTATEDQ1 revenue only ₹85.3 Cr; even at ₹50-55 Cr recovery target, would reach ₹135-140 Cr—still below prior Q1 ₹102.4 Cr
Strong order book visibility ₹699 Cr
MISSOrder book exists but conversion unproven; company lost ₹17.6 Cr in Q1 despite ₹699 Cr backlog
H-Xtreme gaining meaningful traction
UnverifiedNo quantified revenue or unit sales disclosed; product launch claimed last quarter but zero financial impact visible
EBITDA margin will stabilize at 14-16% once revenue crosses ₹850 Cr in 2-3 years
OVERSTATEDQ1 EBITDA -₹14.9 Cr (-17.5% margin); requires 34pp swing from -17.5% to +14-16%—structural gap unaddressed
Execution will normalize by end Q2
PartialSupply chain stabilizing as of August; but underlying operational challenges remain unquantified
Earnings quality
What changed since the last call
Margin recovery horizon pushed
DowngradePrior: 14-16% EBITDA margin target. Current: same target but deferred to ₹850 Cr revenue (2-3 years away). Q1 margin -17.5%—34pp gap.
Order intake target sustained
NeutralFY27 order intake ₹1,000 Cr maintained; achieved ₹200 Cr YTD. Equivalent to prior guidance, no change.
Revenue growth expectations hedged
DowngradePrior call: strong growth from S&P/exports. Current: growth 'subject to execution challenges'; only 80-85% order book conversion assumed.
Near-term execution risks elevated
DowngradePrior: supply chain headwinds acknowledged as 'short-term.' Current: explicitly stating 'challenges in execution, a bit of the industry' and margin pressure from talent investments.
The Q&A
Analysts pressed on margin guidance (Disha), revenue loss quantification (Disha), and WaHa monetization (Nikhil Gupta, Disha). Management acknowledged challenges but remained vague on recovery timing and margins, deflecting with 'subject to stabilization.' Tone: cautious and defensive; analysts were not satisfied on depth of margin recovery plan.
Revenue loss quantification — Disha, Sapphire Capital
Answered₹15 Cr from trading segment, ₹42-43 Cr from manufacturing (S&P/order deferrals) = ₹50-55 Cr total impact
Q2 growth outlook — Disha, Sapphire Capital
PartialSupply chain stabilizing; expect growth phase but subject to 6-week stabilization window; hedged with 'some challenges' in execution
FY27 growth with order book — Disha, Sapphire Capital
Partial80-85% order book conversion = growth; but qualified with 'challenges in execution.' Deflected on exact growth %.
Europe ZLD order details — Disha, Sapphire Capital
PartialEUR600K order, metal slag industry, delivery Q3, export margins better than India. Withheld exact margin % ('too early to tell').
Order conversion & exit order book — Disha, Sapphire Capital
Answered₹1,000 Cr order intake target overall; ₹200 Cr already achieved; large orders in pipeline to convert next 3-4 months.
Margin guidance FY27 & FY28 — Disha, Sapphire Capital
PartialFY27 margins depressed due to investments; 14-16% target once revenue crosses ₹850 Cr (2 years); 15-20% growth next 2 years, 20-25% with EBITDA 12-16% in 2-3 years.
WaHa partnership stake & capital — Nikhil Gupta, Vaayu Capital
AnsweredLess than 2% stake; USD575K infused. Primarily licensing arrangement, exclusive India/UAE rights.
WaHa opportunity size & revenue — Disha, Sapphire Capital
DodgedDehumidification (data centres, battery manufacturing) and AWG both huge; no numbers now, will share Q2. Deflected on specifics.
Order book industry breakup — Subrata Sarkar, Mount Infra Capital
PartialOffered offline discussion; stated alcohol beverage, steel, pharma, chemical, solar as major segments.
Steel sector strategy — Subrata Sarkar, Mount Infra Capital
AnsweredSteel industry pursuing ZLD due to water constraints. Management demonstrated waste-pickle liquor solution, expect to convert to order in 2 months. Strong market position vs competition.
Solar sector expansion — Subrata Sarkar, Mount Infra Capital
AnsweredInitially studied market; now offering innovative, energy-efficient solutions vs incumbent installs. Made inroads with couple of larger players; converting retrofit/efficiency deals.
Semiconductor sector approach — Subrata Sarkar, Mount Infra Capital
AnsweredPartnering with US firm with Micron collaboration. Targeting membrane replacement first, then project segment. Path-to-scale via partners.
Diversification strategy (heat exchanger, etc.) — Subrata Sarkar, Mount Infra Capital
AnsweredCustomers worry about water, energy, carbon footprint together. Heat exchanger born from evaporator R&D need. Solutions connected; same customer base; solve 2 problems.
Carbon capture opportunity — Subrata Sarkar, Mount Infra Capital
AnsweredCarbon potentially larger than water. Government mandates issued (steel, fertilizer, cement). Implementation learning curve 3-5 years. Biological route chosen. Will be large in 3-5 years.
Competitive positioning in ZLD — Nikhil Tiwari, Time Wheel Investment
AnsweredIon Exchange, Thermax, Arvind Envisol, Praj Engineering, Permionics, Hyper Filtration. Company just below Ion Exchange in market share (prior survey 2 yrs ago).
Data centre opportunity — Nikhil Tiwari, Time Wheel Investment
PartialWater recycling and dehumidification both applicable. Sales teams in talks with large players. WaHa cooling + water solutions for data centre cooling. Significant product opportunity on both sides.
Guidance
FY27 order intake ~₹1,000 Cr (₹200 Cr achieved to Aug)
MediumLarge orders in pipeline (domestic + international) expected to convert over next 3-4 months. Contingent on sustained market demand.
FY27 revenue growth expected with 80-85% order book conversion
Low₹699 Cr order book; conversion dependent on execution stability. Management acknowledges 'challenges in execution'; Q1 miss illustrates execution risk.
Q2+ execution acceleration; 'growth phase' post-supply chain normalization
LowContingent on 6-week stabilization window (as of August). Explicitly qualified: 'subject to things playing out over next six weeks.'
14-16% EBITDA margin long-term target maintained
LowDeferred to revenue ₹850 Cr+ (2-3 years out). Near-term margins depressed by talent/execution investments. Q1 EBITDA margin -17.5%.
12-16% EBITDA margin over next 2-3 years with 20-25% growth
LowAssumes successful order book conversion and margin recovery. No detail on margin bridge from -17.5% to +12-16%.
FY27 margins under pressure; cautioned on near-term challenges
HighManagement transparent that FY27 will remain challenged; cited cost inflation (talent, execution) and supply chain instability.
Risks the call surfaced
Execution risk
HighQ1 net loss ₹17.6 Cr despite ₹699 Cr order book suggests significant project costing, scheduling, or resource issues. Large steel orders (₹1,260 Cr) require flawless execution.
Supply chain instability
HighMiddle East conflict caused ₹50-55 Cr revenue loss in Q1. Freight/spare parts normalized by July but remaining upside-downside risks to Q2+ execution.
Margin compression
HighQ1 NPM -19.1% vs target 14-16% EBITDA represents 30-35pp gap. Driven by revenue loss, fixed cost deleverage, and talent/execution investments. Recovery timeline 2-3 years uncertain.
New product/market unproven
MediumH-Xtreme claimed to be 'gaining meaningful traction' but zero revenue recognized in Q1; WaHa partnership only ₹48 Lakh invested, no revenue model detailed; Europe ZLD is first-time execution. Cannibalization risk if these replace core S&P revenue.
Customer concentration
MediumSteel sector order book significant (₹1,260 Cr from largest steel manufacturer); pharma, chemical 'strong' (unquantified). Sector cycle downturn or major customer postponement could crater order intake/conversion.
Management
Score 5/10. Acknowledged execution challenges and external disruptions but vague on specifics of margin recovery plan. Deflected on WaHa monetization details. Transparent on ₹50-55 Cr lost revenue but didn't fully explain why underlying operations so weak. Q1 delivered -16.6% revenue YoY, -₹17.6 Cr loss. Claimed 80-85% order book conversion possible but ₹699 Cr order book couldn't prevent current quarter loss. Track record: missed FY26 guidance on margin/growth.
1 · Q2 FY27
Supply chain stabilization; management expects growth phase contingent on stability
2 · Q3 FY27
Europe ZLD order (EUR600K) delivery; first European ZLD execution
3 · Next 2 months
Steel sector waste-pickle order conversion; management claims ₹1,260 Cr steel order partial delivery
Key risk: execution at scale.
The Order Book Couldn't Save It
A ₹699 crore backlog failed to prevent a ₹17.6 crore loss. Management blamed supply chain, but the numbers suggest execution failures run far deeper.
₹85.3 Cr
-16.6% YoY vs ₹102.4 Cr
-₹17.6 Cr
vs +₹4.1 Cr YoY
-17.5%
target 14–16%
₹699 Cr
FY27 intake ₹1,000 Cr target
The core tension
A ₹699 crore order book did not prevent a ₹17.6 crore net loss in Q1. Management attributed ₹50–55 crore in revenue loss to Middle East supply chain disruptions, order deferrals, and freight volatility. But even accounting for that recovery—which would push the quarter to ₹135–140 crore—the result still falls short of Q1's prior-year ₹102.4 crore baseline. The gap suggests structural execution and costing issues that go well beyond logistics.
The EBITDA margin hit negative ₹14.9 crore, or −17.5%. Management's 14–16% long-term target requires a 31–34 percentage-point swing from current levels. No path to profitability in the near term was articulated on the call.
Management's claims: graded
Supply chain cost ₹50–55 Cr in lost revenue
OverstatedEven with recovery, Q1 would reach ₹135–140 Cr—still below prior Q1 run-rate of ₹102.4 Cr
Strong order book visibility ₹699 Cr
ContradictedOrder book exists but conversion unproven; company posted ₹17.6 Cr loss despite backlog
H-Xtreme gaining meaningful traction
UnverifiedNo quantified revenue or unit sales disclosed; claimed traction saw zero financial impact
EBITDA margin stabilizes at 14–16% once revenue crosses ₹850 Cr (2–3 years)
OverstatedQ1 margin −17.5%; requires 31–34pp swing. No recovery pathway detailed
Execution will normalize by end Q2
PartialSupply chain stabilizing as of call date, but underlying operational challenges remain unquantified
What changed from prior guidance
Margin recovery horizon pushed: from implicit near-term to deferred 2–3 years
Order intake target sustained: ₹1,000 Cr FY27 maintained; ₹200 Cr achieved YTD
Revenue growth hedged: from 'strong growth' to 'subject to execution challenges'; 80–85% order book conversion assumed
Execution risks elevated: new CFO hired; explicit acknowledgement of 'challenges in execution'
The bull-bear ledger
Bull: Concrete order book ₹699 Cr provides Q2–Q3 execution runway; ₹1,000 Cr order intake target implies healthy pipeline demand
Bull: Core ZLD/water treatment market has structural tailwinds (regulatory mandates, water scarcity); new geographies (Europe) and sectors (data centres, semiconductors) offer diversification
Bear: Net loss ₹17.6 Cr despite ₹699 Cr backlog signals project costing failures or demand destruction masked as supply chain delays
Bear: Margin recovery 2–3 years away and unproven; requires simultaneous scale-up and margin recapture from −17.5% to +14–16%
Bear: New products (H-Xtreme, WaHa, Europe entry) lack proof points; H-Xtreme 'gaining traction' but zero revenue; WaHa <2% stake, unmonetized
Bear: FII exit underway (−0.91pp QoQ to 0.37%); institutions are trimming, not adding
Ranked risks
Execution risk on ₹699 Cr order book
HighQ1 loss despite large backlog suggests project costing, resource allocation, or scope management failures. Steel sector mega-orders (₹1,260 Cr largest) require flawless delivery. Cash burn accelerating.
Supply chain re-shock or prolonged instability
High₹50–55 Cr lost in Q1; management assumes stabilization by end Q2 but geopolitical risks remain. Any further disruption delays order conversion and deepens cash burn.
Margin compression unabated
HighQ1 margin −17.5% vs target 14–16%; 31–34pp gap unfilled. Talent/execution investments cited as temporary but no timeline or quantified payoff provided. Risk of structural margin decline if order book can't absorb fixed costs.
New products unproven at scale
MediumH-Xtreme, WaHa, Europe ZLD all nascent. If these cannibalise core S&P revenue instead of expanding TAM, diversification narrative fails. Europe order only EUR600K (~₹50–55 Lakh)—immaterial.
Customer concentration in cyclical sectors
MediumSteel, pharma, chemical dominance; if sector demand softens or mega-orders defer, intake target at risk. ₹1,260 Cr steel order from single customer is both upside and concentration risk.
The street's view
The market's verdict came fast: the stock fell 5.59% on day 1 post-result and a further 4.27% by day 3. That move did not reverse—institutional conviction that the earnings miss is fundamental, not temporary. FII ownership collapsed from 1.28% to 0.37% in a single quarter, a −0.91 percentage-point exodus. DII flat at 7.21%; promoters stable at 51.43%.
The stock now trades at ₹264.65, down 46.71% from its all-time high of ₹496.6. It sits below its 20-day, 50-day, and 200-day moving averages (₹284.67, ₹303.52, ₹348.94 respectively), an unambiguous downtrend. The RSI of 21.5 signals oversold territory—but technical reversion is no comfort when the fundamentals are deteriorating. The 52-week range of ₹235–₹496.6 shows this is not a cyclical dip; the premium valuation has decisively broken.
What to watch next
1 · Q2 order book execution and margin
Management expects 'growth phase' post-supply chain normalization. The litmus test: does Q2 revenue expand vs. Q1, and does EBITDA move toward breakeven? Any repeat of Q1's contraction invalidates the execution story.
2 · Steel mega-order (₹1,260 Cr) delivery milestones
India's largest steel manufacturer order is the largest single backlog item. First revenue recognition on this order in Q2–Q3 would validate execution capability. Deferral or renegotiation would signal deeper project issues.
3 · Cash runway and near-term refinancing
Net loss ₹17.6 Cr in a single quarter with negative EBITDA. Working capital tied up in ₹699 Cr order book. Any guidance on cash position, credit facilities, or refinancing risk should be closely monitored.
Concord Enviro is in the midst of a step-change, not a steady execution cycle. The order book is real, but the company is now burning cash to earn it. Until Q2 shows margin recovery and revenue acceleration, this is a 'prove it' story—not an 'already priced in' opportunity. The single number to track from here: EBITDA. If Q2 posts positive EBITDA and revenue >₹100 Cr, the execution thesis holds and downside is limited. If Q2 repeats Q1 (negative EBITDA, flat or declining revenue), the company's ability to self-fund a ₹850 Cr revenue milestone comes into question, and the stock likely tests the ₹235 Cr low before any reversion.